Author:
Blumenthal Deborah T.,Aisenstein Orna,Ben-Horin Idan,Ben Bashat Dafna,Artzi Moran,Corn Benjamin W.,Kanner Andrew A.,Ram Zvi,Bokstein Felix
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Neurology (clinical),Neurology,Oncology
Reference25 articles.
1. Deistung A, Schweser F, Wiestler B et al (2013) Quantitative susceptibility mapping differentiates between blood depositions and calcifications in patients with glioblastoma. PLoS One 8(3):e57924
2. Seet RC, Rabinstein AA, Lindell PE, Uhm JH, Wijdicks EF (2011) Cerebrovascular events after bevacizumab treatment: an early and severe complication. Neurocrit Care 15(3):421–427
3. Fraum TJ, Kreisl TN, Sul J, Fine HA, Iwamoto FM (2011) Ischemic stroke and intracranial hemorrhage in glioma patients on antiangiogenic therapy. J Neurooncol 105(2):281–289
4. Letarte N, Bressler LR, Villano JL (2013) Bevacizumab and central nervous system (CNS) hemorrhage. Cancer Chemother Pharmacol 71(6):1561–1565
5. Stark-Vance V (2005) Bevacizumab and CPT-11 in the treatment of relapsed malignant glioma. In: Proceedings of the World Federation of Neuro-Oncology Meeting, Edinburgh, UK
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献